TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,168,000 | – | 272,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $28,857,000 | 27.11% |
| Aisling Capital Management LP | 682,923 | $6,720,000 | 3.63% |
| Cormorant Asset Management, LP | 1,174,723 | $11,559,000 | 0.89% |
| Artal Group S.A. | 2,064,262 | $20,312,000 | 0.85% |
| SECTORAL ASSET MANAGEMENT INC | 228,624 | $2,250,000 | 0.40% |
| Logos Global Management LP | 306,236 | $3,013,000 | 0.39% |
| Eventide Asset Management | 1,561,092 | $15,361,000 | 0.24% |
| Blackstone Inc. | 8,089,315 | $79,599,000 | 0.20% |
| HHLR ADVISORS, LTD. | 698,797 | $6,876,000 | 0.14% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $32,370,000 | 0.13% |